Alimera Sciences Stock Price and Value Analysis

Should you buy Alimera Sciences stock? (NasdaqGM:ALIM). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company has fluctuating growth.
  • This stock looks overpriced.
  • This company is not making money.
  • This company pays no dividend.

Inside the ALIM Numbers

ALIM Price
(Alimera Sciences stock price per share)
$0.86
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Drug Manufacturers - Major stocks
[?] Cash Yield -604.67%
[?] Free Cash Flow Jitter 28%

Is Alimera Sciences Stock on Sale?

Based on our analysis, we believe that you should not buy Alimera Sciences right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ALIM Stock?

Does Alimera Sciences have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.